Skip to main content Skip to local navigation
Home » Research Projects & Outputs

Research Projects & Outputs

Social analysis of biomedical innovations, life and health 

Education and public engagement with science and technology 
History, philosophy, and sociology of science 

Policy, political economy and governance of science and technology 
NAME OF PROJECTSocial Pharmaceutical Innovation for Unmet Medical Needs (SPIN) (Douglas 2020-2023)  

STS Undergraduate program development (2020-present Pavri, Lazenby, Monaldi, Douglas, Lungu) 

Mountains, Romanticism and the origins of the biosphere/critical zone (Hamm) 


Social Pharmaceutical Innovation for Unmet Medical Needs (SPIN) (Douglas 2020-2023) 

Sensors, Senses and Sensibility: An Ethnographic Study of  ‘Control’ in Type 1 Diabetes (Mialet) 
Transition pedagogy module development for first year students (2020-present) Pavri and Domenikos 

Women in the History of Quantum Physics: Laura Chalk and the Stark Effect (Monaldi)  

Informing Future Orphan Drug Coverage Using Scenario Studies (iFOCUSS)  
(Douglas 2015-2018) 
Kinds of Evidence in the Assessment of Biofield Healing Modalities (Lazenby) 

From Information Exchange to Technological Innovation: The Early Apple Macintosh User Groups (Lungu, 2015 - present)  
Synthetic Biology for Human Health: Ethical, Legal and Social Issues (SYBHEL) (Douglas 2013-2015) 

Informing Future Orphan Drug Coverage Using Scenario Studies (iFOCUSS)  
(Douglas 2015-2018) 
Mialet, H. (2022). Bodies in Balance: Tracking Type 1 Diabetes. Body & Society, 28(3), 89-113. 


Elwick, J. (2022) Making a Grade: Victorian Examinations and the Rise of Standardized Testing. University of Toronto Press. 

Monaldi, D. (2022). The evolving understanding of quantum statistics, in O. Freire et al. (Eds.), The Oxford Handbook of the History of Quantum Interpretations, (pp. 255-275). Oxford University Press.  


Douglas, C. M. (2023). International Experiences and Made-in-Canada        "Social Pharmaceutical Innovations" as Responses to Challenges Facing Drugs for Rare Diseases. Healthcarepapers, 21(1), 66-72. 

Douglas, C. M., Aith, F., Boon, W., de Neiva Borba, M., Doganova, L., Grunebaum, S., ... & Kleinhout-Vliek, T. (2022). Social pharmaceutical innovation and alternative forms of research, development and deployment for drugs for rare diseases. Orphanet Journal of Rare Diseases, 17(1), 1-13. 

Douglas, C. M., Wilcox, E., Burgess, M., & Lynd, L. D. (2015). Why orphan drug coverage reimbursement decision-making needs patient and public involvement. Health Policy, 119(5), 588-596. 


Mialet, H. (2019) “The Distributed Centered Subject,” in Jill Bennett (ed.), Thinking in The World (London: Bloomsbury), 131-149. 

Douglas, C. M., Panagiotoglou, D., Dragojlovic, N., & Lynd, L. (2021). Methodology for constructing scenarios for health policy research: The case of coverage decision-making for drugs for rare diseases in Canada. Technological Forecasting and Social Change, 171, 120960. 


Mialet, H. (2020). How dogs become accurate instruments: care, attunement, and reflexivity. Humanities and Social Sciences Communications, 7(1), 1-9. 

Lungu, D. and Stachniak, Z. (2011). Following TRACE: The Computer Hobby Movement in Canada. Scientia Canadensis, 34(1), 1-23.


Monaldi, D. (2019). The statistical style of reasoning and the invention of Bose‐Einstein Statistics. Berichte Zur Wissenschaftsgeschichte, 42(4), 307-337. 

Boeckhout, M., & Douglas, C. M. (2015). Governing the research-care divide in clinical biobanking: Dutch perspectives. Life sciences, society and policy11(1), 1-16.

Mialet, H. (2019) “Becoming the Other: The Body in Translation,” in David Gruber and Lynda Walsh (eds.), The Routledge Handbook of Language & Science (Abingdon and New York: Routledge), 375-384. 

Monaldi, D. (2017). Fritz London and the scale of quantum mechanisms. Studies in History and Philosophy of Modern Physics 60, 35-45. 

Douglas, C. M., & Stemerding, D. (2014). Challenges for the European governance of synthetic biology for human health. Life Sciences, Society and Policy10(1), 1-18.

Douglas, C. M. (2016). Bio-objectification of clinical research patients: impacts on the stabilization of new medical technologies. In Vermeulen, N., Tamminen, S., & Webster, A. (Eds.). Bio-objects: life in the 21st century (pp. 59-67). Ashgate.

Hamm, E. (2012). Mining History: People, Knowledge, Power. Earth Sciences History, 31. 

Douglas, C. M., & Stemerding, D. (2013). Governing synthetic biology for global health through responsible research and innovation. Systems and Synthetic Biology7, 139-150.

Webster, A., Douglas, C., & Lewis, G. (2009). Making sense of medicines: ‘lay pharmacology’ and narratives of safety and efficacy. Science as Culture18(2), 233-247.

Hamm, E. (2012). Improving Mennonites in an Age of Revolution. The Conrad Grebel Review, 30(1): 24-51.  


Mialet, H. (2012) “Where STS Would Be Without Latour? What Would Be Missing?” Social Studies of Science, 42/3: 456-461.